U.S. flag

An official website of the United States government

NM_007194.4(CHEK2):c.444+1G>A AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 1, 2019
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001171461.8

Allele description [Variation Report for NM_007194.4(CHEK2):c.444+1G>A]

NM_007194.4(CHEK2):c.444+1G>A

Gene:
CHEK2:checkpoint kinase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q12.1
Genomic location:
Preferred name:
NM_007194.4(CHEK2):c.444+1G>A
Other names:
IVS3+1G>A
HGVS:
  • NC_000022.11:g.28725242C>T
  • NG_008150.2:g.21625G>A
  • NM_001005735.2:c.573+1G>A
  • NM_001257387.2:c.-334+1G>A
  • NM_001349956.2:c.444+1G>A
  • NM_007194.4:c.444+1G>AMANE SELECT
  • NM_145862.2:c.444+1G>A
  • LRG_302t1:c.444+1G>A
  • LRG_302:g.21625G>A
  • NC_000022.10:g.29121230C>T
  • NM_001005735.1:c.573+1G>A
  • NM_007194.3:c.444+1G>A
Note:
NCBI staff provided an HGVS expression for allelic variant 604373.0013 by confirming that the allele introduced an Hpy188 III site in the product of primers Ch2/3f and Ch2/3r Cybulski et al.,2004 (PubMed 15492928).
Nucleotide change:
IVS2DS, G-A, +1
Links:
OMIM: 604373.0013; dbSNP: rs121908698
NCBI 1000 Genomes Browser:
rs121908698
Molecular consequence:
  • NM_001005735.2:c.573+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001257387.2:c.-334+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001349956.2:c.444+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_007194.4:c.444+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_145862.2:c.444+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
Functional consequence:
sequence variant affecting splice donor [Sequence Ontology: SO:1000072]

Condition(s)

Name:
Familial cancer of breast
Synonyms:
Breast cancer, familial; Hereditary breast cancer
Identifiers:
MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480
Name:
Li-Fraumeni syndrome 2 (TPDS4)
Synonyms:
TUMOR PREDISPOSITION SYNDROME 4; CANCER PREDISPOSITION SYNDROME, CHEK2-RELATED
Identifiers:
MedGen: C5882668; Orphanet: 524; OMIM: 609265

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001251372King Laboratory, University of Washington
no assertion criteria provided
Pathogenic
(Sep 1, 2019)
germlineresearch

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedresearch

Citations

PubMed

Characterization of splice-altering mutations in inherited predisposition to cancer.

Casadei S, Gulsuner S, Shirts BH, Mandell JB, Kortbawi HM, Norquist BS, Swisher EM, Lee MK, Goldberg Y, O'Connor R, Tan Z, Pritchard CC, King MC, Walsh T.

Proc Natl Acad Sci U S A. 2019 Dec 26;116(52):26798-26807. doi: 10.1073/pnas.1915608116. Epub 2019 Dec 16.

PubMed [citation]
PMID:
31843900
PMCID:
PMC6936554

Details of each submission

From King Laboratory, University of Washington, SCV001251372.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024